Pelnac dermal substitute to enhance its takeoff in deep dermal burn injuries of upper limb: A Randomized Controlled Trial

A new modification in the application of Pelnac dermal substitute to enhance its takeoff in deep dermal burn injuries of upper limb: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202410749855817

Enrollment

Registered

2024-10-04

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury, Occupational Diseases, Poisoning

Interventions

Graftonly group

Pelnac group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who come to the emergency room with deep dermal burn injuries on their upper limbs that need to be excised and who arrive within the first 24 hours after being burned.

Exclusion criteria

Exclusion criteria: 1-Refusal to participate in the study 2- people with a diagnosed history of hypersensitivity to porcine-derived preparations and bronchial asthma. 3- propensity to allergic conditions such as urticarial and smoking. 4- patients not fit for surgery. 5-patients with unstable conditions, e.g., multiple traumas and serious inhalation injuries.

Design outcomes

Primary

Measure	Time frame
Primary outcome: The percentage of success of graft taken in both groups.	—

Secondary

Measure	Time frame
Scar quality was assessed using the Vancouver Scar Scale (VSS);Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire.;Smiley's face 1-5 rating.	—

Countries

Egypt

Contacts

Public Contacthidi ashraf

lecturer of plastic surgery

Heidi.ashraf.r@hotmail.com00201020846185

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026